Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
4.260
0.00 (0.00%)
Jan 27, 2026, 9:30 AM EST
Renalytix Market Cap
Renalytix has a market cap or net worth of $35.5 million as of January 28, 2026. Its market cap has decreased by -25.47% in one year.
Market Cap
35.50M
Enterprise Value
40.12M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.26
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 35.50M, a decrease of -57.98%. That is a compound annual growth rate of -11.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 35.50M | 2.29% |
| Dec 31, 2025 | 34.70M | -22.15% |
| Dec 31, 2024 | 44.57M | 125.93% |
| Dec 29, 2023 | 19.73M | -69.84% |
| Dec 30, 2022 | 65.42M | -89.22% |
| Dec 31, 2021 | 607.05M | 26.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HFB Financial | 36.52M |
| High Country Bancorp | 36.51M |
| Newbury Street Acquisition | 36.44M |
| Elite Health Systems | 36.32M |
| Mountain Crest Acquisition V | 35.31M |
| Hocking Valley Bancshares | 35.15M |
| Kidoz | 35.12M |
| LakeShore Biopharma | 34.82M |